Amprol 25% Type A Medicated Article

This page contains information on Amprol 25% Type A Medicated Article for veterinary use.
The information provided typically includes the following:

Amprol 25% Type A Medicated Article Indications
Warnings and cautions for Amprol 25% Type A Medicated Article
Direction and dosage information for Amprol 25% Type A Medicated Article

Amprol 25% Type A Medicated Article

This treatment applies to the following species:

Company: Huvepharma

(amprolium)

Approved by FDA under NADA # 012-350

INDICATIONS FOR USE:

AMPROL 25% (amprolium) Type A medicated article is intended for use in (1) preventing outbreaks of coccidiosis in growing chickens, turkeys, and pheasants and (2) development of active immunity to coccidiosis in replacement chickens. AMPROL 25% is also intended for use in the prevention and treatment of coccidiosis in laying chickens.

WITHDRAWAL PERIODS:

No withdrawal period is required when used according to labeling.

ACTIVE DRUG INGREDIENT: Amprolium

25%

Ingredients: Corn Gluten Feed and Soybean Oil

Storage

Store at or below 25°C (77°F), excursions permitted to 40°C (104°F). Avoid prolonged exposure to high humidity.

Mixing Directions

AMPROL^® 25% (amprolium) Type A medicated article should be thoroughly and evenly mixed in the feed. AMPROL 25% may be used to manufacture a Type C medicated feed in the concentration range of 0.004% to 0.025%. The table below shows the amount of AMPROL 25% to be used in each ton (2000 lb) of feed to obtain desired levels of amprolium in the Type C medicated feed.

To aid in even distribution of AMPROL 25% in the finished feed, prepare a mixture of AMPROL 25% in a portion of complete feed ingredient before mixing into the finished ration. Blend the mixture with the remainder of the finished feed and mix thoroughly.

Feeding Level of Amprolium in Type C Medicated Feed	Use This Amount of AMPROL 25% Per Ton
0.004%	5 oz
0.006%	8 oz
0.008%	10 oz
0.0125%	1 lb
0.0175%	1 lb 6 1/2 oz
0.025%	2 lb

Amount And Directions For Use

CHICKENS

Broilers:

Prevention:

Use 0.0125% amprolium Type C medicated feed continuously for most field conditions as they exist under modern management practices. Where severe coccidiosis conditions exists and where immunity is not required, use 0.025% amprolium Type C medicated feed. For field conditions where only E. tenella is the major problem, use 0.008%-0.0125% amprolium Type C medicated feed.

Increasing level of amprolium may not prevent coccidiosis caused by strains of Eimeria commonly found to be resistant to Amprolium.

Replacements:

Immunity Development or Prevention Program:

Where immunity development is not desirable, use 0.0125%-0.025% amprolium Type C medicated feed continuously from day old until onset of production.

Immunity Development Program:

Use 0.004%-0.0125% amprolium Type C medicated feed continuously until onset of production.

Selection of the level to be used should be based upon comparative hazard of infection with cecal and intestinal species. The higher levels will interfere with the development of immunity to E. tenella (cecal).

The following are suggested feeding schedules for various conditions of coccidial exposure. The planning and evaluation of any program should be in the hands of a veterinarian or poultry pathologist who is familiar with the specific operation and with the general nature of disease problems in the area.

1. Severe exposure	2. Moderate exposure	3. Slight exposure
0-5 weeks of age 0.0125%	0-5 weeks of age 0.008%-0.0125%	0-5 weeks of age 0.004%-0.0125%
5-8 weeks of age 0.008%-0.0125%	5-8 weeks of age 0.006%-0.0125%	5-8 weeks of age 0.004%-0.0125%
over 8 weeks of age 0.004%-0.0125%	over 8 weeks of age 0.004%-0.0125%	over 8 weeks of age 0.004%-0.0125%

LAYING CHICKENS:	Treatment:	Use 0.025% amprolium Type C medicated feed for two weeks in severe outbreaks or 0.0125% amprolium Type C medicated feed for two weeks in moderate outbreaks.
LAYING CHICKENS:	Prevention:	Use 0.0125% amprolium Type C medicated feed continuously.
TURKEYS:	Prevention:	Use 0.0125%-0.025% amprolium Type C medicated feed continuously.
PHEASANTS:		For the prevention of coccidiosis in growing pheasants caused by Eimeria colchici, E. duodenalis, and E. phasiani.

Type C medicated feed with 0.0175% amprolium should be fed continuously as the sole ration.

Amprol 25% Type A Medicated Article Caution

Use as the sole source of amprolium.

Do not change the litter while giving this feed unless absolutely necessary.

If losses exceed 0.5% in a 2-day period, obtain an accurate diagnosis, and follow the instructions of your veterinarian or poultry pathologist.

Losses may result from intercurrent disease or other conditions affecting drug intake which can contribute to the virulence of coccidiosis under field conditions.

In replacement flocks the grower must expect that excessive exposure to one or more species may overwhelm the drug in some flocks and prompt treatment will be required.

Fertility, hatchability, and other reproductive data are not available on amprolium in breeding pheasants.

Do not use in feeds containing bentonite.

Restricted Drug (California) - Use Only as Directed.

User Safety Warning

Not for human use. Keep out of reach of children.

Contact Huvepharma Inc. at 1-877-994-4883 or http://www.huvepharma.us. For additional information about reporting side effects for animal drugs, contact FDA at 1-888-FDA-VETS or http://www.fda.gov/reportanimalae.

Manufactured by:

HUVEPHARMA, INC., St. Louis, MO 63116

Distributed by:

HUVEPHARMA, INC., Peachtree City, GA 30269

For questions please call 1-877-994-4883

^® AMPROL is a registered trademark of Huvepharma, Inc.

Huvepharma, Inc., 525 Westpark Drive, Suite 230, Peachtree City, GA 30269

Net Wt.:

Product

50 lb (22.68 kg)

956150

5046-03

Rev 06-2022

CPN: 1309004.2

HUVEPHARMA, INC.
525 WESTPARK DR., SUITE 230, PEACHTREE CITY, GA, 30269

Telephone:		770-486-7212
Toll-Free:		877-994-4883
Fax:		770-486-7217
Website:		www.huvepharma.us

THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.